Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab. (Q54374397)

28 May 2018

title

Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab. (English)

1 reference

28 May 2018

1 reference

9

1 reference

28 May 2018

Valeria Pietropaolo

10

1 reference

28 May 2018

Federica Ferrari

Federica Ferrari

3

0 references

Giovanni Di Nardo

Giovanni Di Nardo

4

0 references

Fernanda Chiarini

8

Fernanda Chiarini

1 reference

28 May 2018

Anna Bellizzi

1

Anna Bellizzi

1 reference

28 May 2018

Elena Anzivino

2

Elena Anzivino

1 reference

28 May 2018

Monica Mischitelli

7

Monica Mischitelli

1 reference

28 May 2018

Daniela Fioriti

6

Daniela Fioriti

1 reference

28 May 2018

author name string

Maria Teresa Colosimo

5

1 reference

28 May 2018

publication date

6 May 2011

1 reference

28 May 2018

published in

Journal of NeuroVirology

1 reference

28 May 2018

volume

17

1 reference

28 May 2018

issue

4

1 reference

28 May 2018

page(s)

303-313

1 reference

28 May 2018

Genotypes of JC virus in East, Central and Southwest Europe

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Treatment of luminal and fistulizing Crohn's disease with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Polyomaviruses BK- And JC-DNA quantitation in kidney allograft biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Comparison between prospective and retrospective evaluation of Crohn's disease activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

The safety and side effects of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Reemergence of PML in natalizumab-treated patients--new cases, same concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Evolving paradigms in the pathogenesis of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Rearrangement patterns of JC virus noncoding control region from different biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Transcending conventional therapies: the role of biologic and other novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Biologic therapy of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

The Ets protein Spi-B is expressed exclusively in B cells and T cells during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

21 January 2018

1 reference

12 December 2020

Human polyomavirus JC virus genome

1 reference

12 December 2020

Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

1 reference

12 December 2020

Infliximab and the risk of latent viruses reactivation in active Crohn's disease

1 reference

12 December 2020

Viral infection in bone marrow transplants: Is JC virus involved?

1 reference

12 December 2020

Nucleotide sequence of the region encompassing the JC virus origin of DNA replication

1 reference

12 December 2020

PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals.

1 reference

12 December 2020

10.1007/S13365-011-0036-3

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018